Table 2 Changes in primary and secondary outcome variables
Variable | Triheptanoin | Placebo | p value |
|---|---|---|---|
Total paroxysmal events | 3.5 (2.1) | 3.2 (2.1) | 0.646 |
Motor-epilepticparoxysmal events | 3.4 (1.9) | 3.2 (2.0) | 0.585 |
Composite score | 1015 (1058) | 723.9 (767.3) | 0.059 |
CGI – patient | 3.7 (1.5) | 3.2 (1.0) | 0.481 |
CGI – physician | 3.8 (0.6) | 3.3 (0.9) | 0.262 |